Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marie Sundqvist
Observed names:
M Sundqvist,
M. Sundqvist,
Sundqvist, Marie
Institution:
Landstinget i Kalmar län
Observed institutions:
F. Hoffmann-La Roche AG,
Uppsala University,
Uppsala University Hospital,
Sundsvall Municipality,
University Hospital of Umeå,
Örebro University Hospital,
Länssjukhuset i Kalmar,
Landstinget i Kalmar län
show all 8
OpenAlex ID:
A5110125576
Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival
2014
·
N.P. Tobin
, J.C. Harrell
, et al.
·
Annals of Oncology
·
98
PDF
Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study)
2019
·
A Karakatsanis
, A-F Hersi
, et al.
·
British journal of surgery
·
40
Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy
2013
·
Chikako Suzuki
, Lennart Blomqvist
, et al.
·
Medical Oncology
·
8
Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer
2018
·
Carina Forsare
, Martin Bak
, et al.
·
BMC Cancer
·
5
PDF
Use of Subcutaneous and Intravenous Trastuzumab: Real-World Experience from Three Hospitals in Sweden
2019
·
Antonis Valachis
, Marie Sundqvist
, et al.
·
Future Oncology
·
4
Axillary evaluation in ductal cancer in situ of the breast: challenging the diagnostic accuracy of clinical practice guidelines
2021
·
Andreas Karakatsanis
, Petros Charalampoudis
, et al.
·
British journal of surgery
·
3
Abstract P2-01-19: SentiNot: A way to avoid sentinel node biopsy (SNB) in patients with a preoperative diagnosis of ductal cancer in situ (DCIS)
2017
·
A Karakatsanis
, HM Olofsson
, et al.
·
Cancer Research
·
3
Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
2025
·
Erik Olsson
, Henrik Lindman
, et al.
·
The Breast
·
2
PDF
Abstract P6-17-24: Use of subcutaneous and intravenous trastuzumab: Real-world experience from three hospitals in Sweden
2019
·
A Valachis
, L Carlsson
, et al.
·
Cancer Research
·
1
Abstract PO4-15-05: Genomic characterization and molecular predictive biomarkers for chemotherapy in a real-world population with metastatic triple-negative breast cancer
2024
·
Erik Olsson
, Henrik Lindman
, et al.
·
Cancer Research
Use of Superparamagnetic Iron Oxide (SPIO) Nanoparticles to Avoid Upfront Sentinel Node Dissection (SLND) in Patients with Ductal Cancer in Situ (DCIS): An Update of the Sentinot Study.
2020
·
Andreas Karakatsanis
, Abdi Hersi
, et al.
·
European Journal of Surgical Oncology
Lymphovascular invasion and p53 as risk factors for local recurrence after mastectomy
2017
·
T. Halldorsdottir
, M. Sundqvist
, et al.
·
The Breast
PDF
125P Components of the PI3K/Akt pathway as prognostic factors in metastatic HER2-positive breast cancer treated with trastuzumab
2016
·
C. Veenstra
, S. Ellegård
, et al.
·
Annals of Oncology
Prolonged Tamoxifen Treatment Increases Survival for Patients With Primary Breast Cancers Expressing High Levels of Vegf
2009
·
B Chavez Sanchez
, Marie Sundqvist
, et al.
Show more works
View as search
Works count:
17
Citation count:
164
H-index:
4
I10-index:
2
Year
Topic
Type